Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

SZSE:300255 Stock Report

Market Cap: CN¥17.5b

Hebei Changshan Biochemical Pharmaceutical Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Hao Cai

Chief executive officer

CN¥500.2k

Total compensation

CEO salary percentagen/a
CEO tenure1.4yrs
CEO ownershipn/a
Management average tenure3.3yrs
Board average tenure3.5yrs

Recent management updates

Recent updates

Calculating The Intrinsic Value Of Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SZSE:300255)

Oct 30
Calculating The Intrinsic Value Of Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SZSE:300255)

Subdued Growth No Barrier To Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SZSE:300255) With Shares Advancing 55%

Oct 08
Subdued Growth No Barrier To Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SZSE:300255) With Shares Advancing 55%

Hebei Changshan Biochemical Pharmaceutical (SZSE:300255) Is Carrying A Fair Bit Of Debt

Sep 30
Hebei Changshan Biochemical Pharmaceutical (SZSE:300255) Is Carrying A Fair Bit Of Debt

Pinning Down Hebei Changshan Biochemical Pharmaceutical Co., Ltd.'s (SZSE:300255) P/S Is Difficult Right Now

Jul 25
Pinning Down Hebei Changshan Biochemical Pharmaceutical Co., Ltd.'s (SZSE:300255) P/S Is Difficult Right Now

Is Hebei Changshan Biochemical Pharmaceutical (SZSE:300255) Using Too Much Debt?

May 27
Is Hebei Changshan Biochemical Pharmaceutical (SZSE:300255) Using Too Much Debt?

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SZSE:300255) May Have Run Too Fast Too Soon With Recent 25% Price Plummet

Apr 15
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SZSE:300255) May Have Run Too Fast Too Soon With Recent 25% Price Plummet

Hebei Changshan Biochemical Pharmaceutical Co., Ltd.'s (SZSE:300255) 30% Share Price Surge Not Quite Adding Up

Mar 01
Hebei Changshan Biochemical Pharmaceutical Co., Ltd.'s (SZSE:300255) 30% Share Price Surge Not Quite Adding Up

CEO

Hao Cai (49 yo)

1.4yrs

Tenure

CN¥500,200

Compensation


Leadership Team

NamePositionTenureCompensationOwnership
Hao Cai
General Manager1.4yrsCN¥500.20kno data
Xiaohua Yue
Deputy GM & CFOless than a yearCN¥70.00kno data
Yunxia Sun
Deputy GM & Non-Independent Director3.3yrsCN¥500.60kno data
Zhihua Li
Deputy General Manager4.4yrsCN¥500.20k0.032%
CN¥ 5.5m
Qing Zhang
Deputy General Manager4.4yrsCN¥671.70kno data

3.3yrs

Average Tenure

50yo

Average Age

Experienced Management: 300255's management team is considered experienced (3.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Yunxia Sun
Deputy GM & Non-Independent Director3.5yrsCN¥500.60kno data
Xiaodong Gao
Chairman of the Board16.2yrsCN¥1.00m0.17%
CN¥ 29.2m
Shuxuan Gao
Chairman of the Supervisory Board5.9yrsno datano data
Jinliang Wang
Non-Employee Supervisor8.2yrsno datano data
Deying Cao
Independent Director2.9yrsCN¥60.00kno data
Xiangjun Wang
Independent Director2.9yrsCN¥60.00kno data
Zuolin Wang
Independent Directorno dataCN¥60.00kno data
Jie Gao
Directorless than a yearno datano data

3.5yrs

Average Tenure

51yo

Average Age

Experienced Board: 300255's board of directors are considered experienced (3.5 years average tenure).